A Study of Efficacy and Safety of AX-8 in Chronic Cough
Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, crossover, multicenter study of AX-8
in participants with unexplained or refractory chronic cough designed to evaluate the
effectiveness of AX-8 in reducing cough frequency.